The Effectiveness of Sharing Decision-making Program Interventions in the Early Stage of HCC to Reduce Treatment Decisions Conflicts and Improving Decision-making Satisfaction
Phase: NA
Conditions: Hepatocellular Cancer
Sponsor: National Taipei University of Nursing and Health Sciences

 
 
 
Title: Effectiveness of Sharing Decision-making 
program 
intervention 
in 
Hepatocellular 
Carcinoma patients on treatment decision to 
reduce Patient's treatment decision conflict 
and improving Decision Satisfaction 
 
 
 
 
NCT number: NCT03926039 
 
 
Document date: 2021.2.16 
 
 

Study Protocol 
BACKGROUND: Hepatocellular cancer is a disease with a high incidence 
and a high mortality rate in global and Taiwan. New technologies and 
expanded indications for standard therapies have led to improved patient 
outcomes. Choosing a therapeutic plan has become increasingly complex 
and requires consideration of multiple factors including tumor burden, 
baseline liver function, available medical resources, and techniques in 
treatment procedures between countries. The choice of cancer treatment 
is extremely important and involves a high-risk, complex, and difficult 
decision-making process for cancer patients. When people lack adequate 
information or skills, they may make less than optimal decisions, due to 
the individual patient factors and tumor stage differences, cancer 
treatment decisions by patients still lead to uncertainty. 
PURPOSE: Shared decision-making (SDM) is defined as a patient-centric 
collaborative process that enables individuals and their healthcare 
providers to make decisions together. This is a method of decision-making 
that combines a person's values, goals, and evidence about advantages, 
risks, and treatment uncertainty. There is a lack of research on shared 
decision making with treatment decisions for patients with liver 
cancer .Therefore, this study will develop interventions based on the 
theory of sharing decision-making clinical practice models, and explore its 
effectiveness in assisting patients with liver cancer in making treatment 
decisions. 
 
METHODS: After screening for inclusion and exclusion criteria, cases 
eligible for admission were recruited, and the researcher explained the 
research purpose and steps to the research subjects in the clinic room and 
completed the consent form after the patient agreed to participate in the 
study. Randomly assigned to control or experimental groups. Individual 
supervisors collected pre-test data (T1) from research subjects, including 
basic demographic data, knowledge scale, health Literacy scale, decision-
control preferences, decision-making self-efficacy, and decision conflict 
questionnaire. 72 people are eligible for recruitment criteria. The number 
of effective samples was 69. 
 
TDATA ANALYSIS: Data were analyzed using the Statistical Package for 
Social Sciences 22.0 (SPSS, Inc., Chicago, IL, USA). Descriptive analyses 

were used to describe study variables. Independent t-tests and one-way 
analysis of variance (ANOVA) were performed to analyze the baseline 
equivalent between study groups. The ANCOVA (analysis of covariance) 
to check the effectiveness of the intervention.